OTCMKTS:ULUR ULURU (ULUR) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ULUR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume6,691 shsMarket Capitalization$5.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings Get ULURU alerts: Email Address Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here About ULURU Stock (OTCMKTS:ULUR)ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. was founded in 1987 and is based in Addison, Texas.Read More Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here ULUR Stock News HeadlinesApril 27, 2024 | msn.comTop Safari Location in Australia for WildlifeApril 26, 2024 | uk.style.yahoo.comTracing 30 years of Priscilla, Queen of the Desert on our own Australian adventureApril 27, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 26, 2024 | yahoo.comDozens of pilot whales dead after massive stranding on Western Australia beachApril 21, 2024 | theguardian.comThe rise of booze-free backpacking: why gen Z are choosing to travel soberApril 18, 2024 | afr.comTruth-telling risks inflaming community conflict: reportApril 18, 2024 | afr.comIt’s political spending that feeds inflation, not Coles and WooliesApril 18, 2024 | theguardian.comTruth, colonisation and Yoorrook: what is Victoria’s truth-telling inquiry and what will it achieve?April 27, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 14, 2024 | msn.comThe cost of marrying a British princeApril 14, 2024 | msn.comFormer soldier returns boomerang from nuclear test era to Maralinga's traditional ownersApril 12, 2024 | msn.comThere’s nothing to sea here: Cruise dining goes inland for some spectacular new experiencesApril 9, 2024 | msn.comHow to see the next 20 years of eclipses, including the eclipse of a lifetimeApril 9, 2024 | msn.comUltra-rare, bizarre-looking blind mole photographed in AustraliaApril 8, 2024 | msn.comI Lived Out of a Backpack for 2 Years on Working Holidays, and These Are the 17 Items I Relied on — From $8April 5, 2024 | msn.comNews live: heavy rain causes NSW train, bus delays as severe east coast weather continues; two Australians missing after Taiwan quakeApril 5, 2024 | theguardian.com‘Time to be fearless’: NT attorney general urges Australian leaders to pursue treaty after voice defeatApril 4, 2024 | msn.com66 Of The World's Wonders You Can't MissApril 4, 2024 | msn.com7 Fun & Exciting Ways to Teach Your Kids About Culture While TravelingApril 4, 2024 | afr.comSam Mostyn goes from boardroom to YarralumlaApril 4, 2024 | msn.comSam Mostyn, Australia's next Governor-General, says the country wasn't 'big enough' to vote for the Indigenous Voice - and shares her two word reaction to its landslide defeatApril 3, 2024 | msn.com10 of the world’s most beautiful Unesco World Heritage SitesApril 2, 2024 | msn.comGreens did not donate or spend money on Voice referendum campaign, according to AEC disclosuresApril 2, 2024 | msn.com‘Clear message’: Jacinta’s big call on Voice funds as AEC financial disclosures reveal biggest Yes, No donorsApril 1, 2024 | afr.comRamsay Foundation splashed $7m on failed Voice campaignApril 1, 2024 | msn.comBig spenders of Voice campaign revealedApril 1, 2024 | theguardian.comYes campaign groups received more than five times as much in donations as no side in voice referendumSee More Headlines Receive ULUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ULURU and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:ULUR CUSIPN/A CIK1168220 Webwww.uluruinc.com Phone(214) 905-5145Fax214-905-5130Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares30,573,000Free Float30,237,000Market Cap$5.35 million OptionableNot Optionable Beta-3.13 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMs. Vaidehi A. Shah (Age 47)Chairman & CEO Comp: $101.88kMr. Anish Vithaldas Shah (Age 57)VP & Director Ms. Oksana V. Tiedt (Age 48)VP of Clinical & International Affairs and Director Mr. P. K Ramachandran (Age 70)Chief Financial Officer Key CompetitorsPaxMedicaNASDAQ:PXMDSonnet BioTherapeuticsNASDAQ:SONNKintara TherapeuticsNASDAQ:KTRAAvenue TherapeuticsNASDAQ:ATXIAlzamend NeuroNASDAQ:ALZNView All Competitors ULUR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ULURU own? Based on aggregate information from My MarketBeat watchlists, some companies that other ULURU investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Jaguar Health (JAGX). How do I buy shares of ULURU? Shares of ULUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ULUR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ULURU Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
